Compounds > technetium tc 99m sestamibi
Page last updated: 2024-08-16

technetium tc 99m sestamibi and Osteolysis

technetium tc 99m sestamibi has been researched along with Osteolysis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Solav, S1
Chen, J; Chen, S; Shi, H1
Fuerst, MM; Giles, FJ; Gupta, PK; Kusuanco, DA; Lawrence, GN; Lim, SW; Look, RM; Waxman, AD1
Alexandrakis, MG; Christophoridou, AV; Karkavitsas, N; Kyriakou, DS; Malliaraki, N; Passam, FH1

Other Studies

4 other study(ies) available for technetium tc 99m sestamibi and Osteolysis

ArticleYear
Bone scintiscanning in osteolytic lesions.
    Clinical nuclear medicine, 2004, Volume: 29, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Osteitis Deformans; Osteolysis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tuberculosis, Osteoarticular

2004
Parathyroid and bone scintigraphy in hyperparathyroidism.
    Clinical nuclear medicine, 2005, Volume: 30, Issue:11

    Topics: Bone and Bones; Humans; Hyperparathyroidism; Male; Middle Aged; Osteolysis; Parathyroid Glands; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Whole Body Imaging

2005
Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation.
    Leukemia & lymphoma, 1996, Volume: 20, Issue:5-6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dexamethasone; Disease Progression; Hematopoietic Stem Cell Transplantation; Humans; Humerus; Male; Mitoxantrone; Multiple Myeloma; Osteolysis; Radionuclide Imaging; Technetium Tc 99m Sestamibi

1996
Correlation between the uptake of Tc-99m-sestaMIBI and prognostic factors in patients with multiple myeloma.
    Clinical and laboratory haematology, 2002, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Humans; Male; Middle Aged; Multiple Myeloma; Osteolysis; Prognosis; Statistics, Nonparametric; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed

2002